Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

APPOINTMENTS AND ADVANCEMENTS

Oct. 21, 1991

FDA PANEL TO REVIEW CENTOCOR'S MYOSCINT

Oct. 21, 1991

FDA APPROVES PROSORBA COLUMN TRIALS

Oct. 18, 1991

DEPRENYL CRADA WITH ITRI

Oct. 18, 1991

CELLPRO MARKETS FIRST PRODUCT

Oct. 18, 1991

MYCOGEN FILES FOR OFFERING

Oct. 18, 1991

SOMATIX TO MERGE WITH GENESYS

Oct. 18, 1991

EPOGEN, NEUPOGEN SALES DRIVE AMGEN EARNINGS

Oct. 18, 1991

CAMBRIDGE BIO RAISES $25.6 MILLION

Oct. 18, 1991

IMMUNEX BEGINS SARCOMA TREATMENT TRIALS

Oct. 18, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...